1. Home
  2. BNZI vs BRTX Comparison

BNZI vs BRTX Comparison

Compare BNZI & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banzai International Inc.

BNZI

Banzai International Inc.

HOLD

Current Price

$1.23

Market Cap

9.6M

Sector

N/A

ML Signal

HOLD

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

HOLD

Current Price

$1.10

Market Cap

9.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNZI
BRTX
Founded
2016
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Managed Health Care
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6M
9.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BNZI
BRTX
Price
$1.23
$1.10
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$30.00
N/A
AVG Volume (30 Days)
537.6K
80.3K
Earning Date
11-14-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,650,176.00
$383,400.00
Revenue This Year
$223.24
$112.14
Revenue Next Year
$31.42
$139.81
P/E Ratio
N/A
N/A
Revenue Growth
147.06
1.70
52 Week Low
$1.09
$0.98
52 Week High
$27.00
$2.55

Technical Indicators

Market Signals
Indicator
BNZI
BRTX
Relative Strength Index (RSI) 37.37 40.24
Support Level $1.14 $1.06
Resistance Level $1.40 $1.17
Average True Range (ATR) 0.15 0.11
MACD 0.04 0.01
Stochastic Oscillator 31.83 27.80

Price Performance

Historical Comparison
BNZI
BRTX

About BNZI Banzai International Inc.

Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Share on Social Networks: